|
|
Volumn 184, Issue , 2015, Pages 125-126
|
|
Emerging evidence regarding statins use as novel endometriosis targeted treatment: Real "magic pills" or "trendy" drugs? Some considerations
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
GONADORELIN AGONIST;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
SIMVASTATIN;
BIOLOGICAL ACTIVITY;
CONSERVATIVE TREATMENT;
DISEASE SEVERITY;
DRUG SAFETY;
ENDOMETRIOSIS;
FEMALE FERTILITY;
FIRST TRIMESTER PREGNANCY;
FOLLOW UP;
GERM LINE;
GONAD FUNCTION;
GRANULOSA CELL;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
LETTER;
LUTEAL PHASE;
MOLECULAR MECHANICS;
NONHUMAN;
OVARIAN RESERVE;
PLEIOTROPY;
POSTOPERATIVE CARE;
PREGNANCY;
PRIORITY JOURNAL;
RISK FACTOR;
SAMPLE SIZE;
SOMATIC CELL;
SYMPTOM;
TERATOGENESIS;
FEMALE;
ENDOMETRIOSIS;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
|
|
EID: 84920683865
PISSN: 03012115
EISSN: 18727654
Source Type: Journal
DOI: 10.1016/j.ejogrb.2014.11.018 Document Type: Letter |
|
Times cited : (10)
|
|
References (5)
|
